BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22242615)

  • 1. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.
    Ripoll C; Lastra P; Rincón D; Catalina V; Bañares R
    Scand J Gastroenterol; 2012 Feb; 47(2):204-11. PubMed ID: 22242615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH; Park SH; Kim GW; Lee WJ; Hong WK; Ryu MS; Park KT; Lee MY; Lee CW; Kim JH; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.
    Ripoll C; Bañares R; Rincón D; Catalina MV; Lo Iacono O; Salcedo M; Clemente G; Núñez O; Matilla A; Molinero LM
    Hepatology; 2005 Oct; 42(4):793-801. PubMed ID: 16175621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
    Park SH; Park HY; Kang JW; Park JS; Shin KJ; Kim CH; Suk KT; Baik GH; Kim JB; Kim DJ; Lee HY
    Hepatogastroenterology; 2012; 59(120):2548-51. PubMed ID: 23178621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study.
    Colecchia A; Colli A; Casazza G; Mandolesi D; Schiumerini R; Reggiani LB; Marasco G; Taddia M; Lisotti A; Mazzella G; Di Biase AR; Golfieri R; Pinzani M; Festi D
    J Hepatol; 2014 Jun; 60(6):1158-64. PubMed ID: 24607624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
    Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
    Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
    J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.
    Turco L; Garcia-Tsao G; Magnani I; Bianchini M; Costetti M; Caporali C; Colopi S; Simonini E; De Maria N; Banchelli F; Rossi R; Villa E; Schepis F
    J Hepatol; 2018 May; 68(5):949-958. PubMed ID: 29331339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.
    Jindal A; Bhardwaj A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 Oct; 115(10):1624-1633. PubMed ID: 32453061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.
    Manousou P; Dhillon AP; Isgro G; Calvaruso V; Luong TV; Tsochatzis E; Xirouchakis E; Kalambokis G; Cross TJ; Rolando N; O'Beirne J; Patch D; Thornburn D; Burroughs AK
    Liver Transpl; 2011 Feb; 17(2):178-88. PubMed ID: 21280191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.